Conduit Pharmaceuticals Inc.

NASDAQ (USD): Conduit Pharmaceuticals Inc. (CDT)

Last Price

1.80

Today's Change

-0.40 (18.18%)

Day's Change

1.75 - 2.19

Trading Volume

645,790

Overview

Market Cap

2 Million

Shares Outstanding

1 Million

Avg Volume

637,509

Avg Price (50 Days)

7.55

Avg Price (200 Days)

78.18

PE Ratio

-0.09

EPS

-20.40

Earnings Announcement

18-Nov-2024

Previous Close

2.20

Open

2.18

Day's Range

1.75 - 2.1901

Year Range

1.75 - 392.0

Trading Volume

645,790

Price Change Highlight

1 Day Change

-18.18%

5 Day Change

-29.13%

1 Month Change

-74.72%

3 Month Change

-82.89%

6 Month Change

-90.01%

Ytd Change

-76.22%

1 Year Change

-99.26%

3 Year Change

-99.82%

5 Year Change

-99.82%

10 Year Change

-99.82%

Max Change

-99.82%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment